US 11224646
Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis
granted A61KA61K2039/5256A61K2039/53
Quick answer
US patent 11224646 (Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis) held by The Regents of the University of California expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/5256, A61K2039/53, A61K2039/543, A61K2039/545